AlloVir
Why Robinhood?
You can watch AlloVir and buy or sell other stocks, ETFs, and their options commission-free!About ALVR
Kalaris Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for retinal diseases. It is focusing on developing TH103, a novel anti-VEGF agent targeted at treating neovascular and exudative retinal diseases.
ALVR Key Statistics
Stock Snapshot
AlloVir(ALVR) stock is priced at $9.81, giving the company a market capitalization of 183.47M. It carries a P/E multiple of -1.13.
On 2026-02-06, AlloVir(ALVR) stock opened at —, reached a high of —, and a low of —.
AlloVir(ALVR) shares are trading with a volume of 0, against a daily average of 43.24K.
During the past year, AlloVir(ALVR) stock moved between $2.14 at its lowest and $12.90 at its peak.
During the past year, AlloVir(ALVR) stock moved between $2.14 at its lowest and $12.90 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.